Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimer's disease subjects-Reference-Cited by-同舟云学术

Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimer's disease subjects

Published:2016-07 Issue: Volume:43 Page:1-12
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Ciavardelli Domenico,Piras Fabrizio,Consalvo Ada,Rossi Claudia,Zucchelli Mirco,Di Ilio Carmine,Frazzini Valerio,Caltagirone Carlo,Spalletta Gianfranco,Sensi Stefano L.^ORCID

Funder

Italian Department of Education

Italian Department of Health

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference81 articles.

1. A fast diffeomorphic image registration algorithm;Ashburner;Neuroimage,2007

2. Unified segmentation;Ashburner;Neuroimage,2005

3. Towards a whole-body systems [multi-organ] lipidomics in Alzheimer’s disease;Astarita;Prostaglandins. Leukot. Essent. Fatty Acids,2011

4. Profile of memory impairment and gray matter loss in amnestic mild cognitive impairment;Barbeau;Neuropsychologia,2008

5. Carnitine metabolism in Macaca arctoides: the effects of dietary change and fasting on serum triglycerides, unesterified carnitine, esterified (acyl) carnitine, and beta-hydroxybutyrate;Bell;Am. J. Clin. Nutr.,1982

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer's disease;Heliyon;2024-03

2. Individual bioenergetic capacity as a potential source of resilience to Alzheimer’s disease;2024-01-24

3. Large-Scale Population-Based Studies of Blood Metabolome and Brain Health;Current Topics in Behavioral Neurosciences;2024

4. Carnitine metabolites and cognitive improvement in patients with schizophrenia treated with olanzapine: a prospective longitudinal study;Frontiers in Pharmacology;2023-08-17

5. Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives;Ageing Research Reviews;2023-08